Evidence map›Paper›PMID 34021132›Full record

ArticleNature communications2021

Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects.

Jelena Scekic-Zahirovic, Inmaculada Sanjuan-Ruiz, Vanessa Kan, Salim Megat, Pierre De Rossi, Stéphane Dieterlé, Raphaelle Cassel, Marguerite Jamet, Pascal Kessler, Diana Wiesner and 18 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Intrathecal (GActa neuropathologica communications · 2026
    Article
  5. Article
  6. RNArchitects: how hnRNPs shape neuronal landscapes.Brain : a journal of neurology · 2026
    Review
  7. Intrathecal (GbioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 7 institutions in 4 countries.

Jelena Scekic-Zahirovic *Université de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, Strasbourg, France.
Inmaculada Sanjuan-Ruiz *Université de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, Strasbourg, France.ORCID 0000-0002-0855-277X
Vanessa KanInstitute of Clinical Neuroimmunology, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Munich, Germany.
Salim MegatUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, Strasbourg, France.
Pierre De RossiDepartment of Quantitative Biomedicine, University of Zurich, Zürich, Switzerland.ORCID 0000-0002-2356-4269
Stéphane DieterléUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, Strasbourg, France.
Raphaelle CasselUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, Strasbourg, France.
Marguerite JametUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, Strasbourg, France.
Pascal KesslerUniversité de Strasbourg, Inserm, Unité mixte de service du CRBS, UMS 038, Strasbourg, France.ORCID 0000-0003-3323-3647
Diana WiesnerDepartment of Neurology, Ulm University, Ulm, Germany.
Laura TzeplaeffUniversité de Strasbourg, UMR 7364 CNRS, Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Strasbourg, France.
Valérie DemaisPlateforme Imagerie In Vitro, CNRS UPS-3156, NeuroPôle, Strasbourg, France.
Sonu SahadevanDepartment of Quantitative Biomedicine, University of Zurich, Zürich, Switzerland.
Katharina M HembachDepartment of Quantitative Biomedicine, University of Zurich, Zürich, Switzerland.ORCID 0000-0001-5041-6205
Hans-Peter MullerDepartment of Neurology, Ulm University, Ulm, Germany.
Gina PicchiarelliUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, Strasbourg, France.
Nibha MishraDepartment of Neurology, The Sean M. Healey and AMG Center for ALS at Mass General, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Stefano AntonucciDepartment of Neurology, Ulm University, Ulm, Germany.ORCID 0000-0002-2583-3522
Sylvie Dirrig-GroschUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, Strasbourg, France.
Jan KassubekDepartment of Neurology, Ulm University, Ulm, Germany.ORCID 0000-0002-7106-9270
Volker RascheUlm University Medical Center, Department of Internal Medicine II, Ulm, Germany.ORCID 0000-0001-8844-3583
Albert LudolphDepartment of Neurology, Ulm University, Ulm, Germany.
Anne-Laurence BoutillierUniversité de Strasbourg, UMR 7364 CNRS, Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Strasbourg, France.ORCID 0000-0002-2317-9280
Francesco RoselliDepartment of Neurology, Ulm University, Ulm, Germany.ORCID 0000-0001-9935-6899
Magdalini PolymenidouDepartment of Quantitative Biomedicine, University of Zurich, Zürich, Switzerland.ORCID 0000-0003-1271-9445
Clotilde Lagier-TourenneDepartment of Neurology, The Sean M. Healey and AMG Center for ALS at Mass General, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-3058-8322
Sabine LiebscherInstitute of Clinical Neuroimmunology, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Munich, Germany. sabine.liebscher@med.uni-muenchen.de.ORCID 0000-0001-5633-8981
Luc DupuisUniversité de Strasbourg, Inserm, Mécanismes centraux et périphériques de la neurodégénérescence, Strasbourg, France. ldupuis@unistra.fr.ORCID 0000-0002-0902-5824
Inserm · FRUniversität Ulm · DECentre National de la Recherche Scientifique · FRUniversity of Zurich · CHBroad Institute · USLudwig-Maximilians-Universität München · DEMunich Cluster for Systems Neurology · DE

Funding

Multimodal analysis and therapeutic targeting of aberrant nucleocytoplasmic compartmentalization in FUS-related neurodegenerative diseaseR01NS108769 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Daryl Angela Bosco, Ankur Jain · 2019 to 2026
$5.2M
NINDS NIH HHS R01 NS108769
6 · The paper itself

Abstract

Gene mutations causing cytoplasmic mislocalization of the RNA-binding protein FUS lead to severe forms of amyotrophic lateral sclerosis (ALS). Cytoplasmic accumulation of FUS is also observed in other diseases, with unknown consequences. Here, we show that cytoplasmic mislocalization of FUS drives behavioral abnormalities in knock-in mice, including locomotor hyperactivity and alterations in social interactions, in the absence of widespread neuronal loss. Mechanistically, we identified a progressive increase in neuronal activity in the frontal cortex of Fus knock-in mice in vivo, associated with altered synaptic gene expression. Synaptic ultrastructural and morphological defects were more pronounced in inhibitory than excitatory synapses and associated with increased synaptosomal levels of FUS and its RNA targets. Thus, cytoplasmic FUS triggers synaptic deficits, which is leading to increased neuronal activity in frontal cortex and causing related behavioral phenotypes. These results indicate that FUS mislocalization may trigger deleterious phenotypes beyond motor neuron impairment in ALS, likely relevant also for other neurodegenerative diseases characterized by FUS mislocalization.

Indexed as

Amyotrophic Lateral SclerosisCytoplasmRNA-Binding Protein FUSSynapsesAnimalsDisease Models, AnimalFemaleGene ExpressionGene Knock-In TechniquesMaleMiceMice, Inbred C57BLMotor NeuronsMutationPhenotypeSynaptic TransmissionFUS protein, mouseRNA-Binding Protein FUS

Identifiers

PMID34021132
PMCPMC8140148
OpenAlexW3160500935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.